Emergent BioSolutions Inc ER4-FF:Frankfurt Stock Exchange

RT Quote | Exchange | EUR
Last | 7:06 PM CEST
58.26quote price arrow down-4.16 (-6.66%)
Volume
261
52 week range
57.00 - 115.00

...

Loading . . .
  • Open64.54
  • Day High64.54
  • Day Low58.00
  • Prev Close58.26
  • 52 Week High115.00
  • 52 Week High Date08/06/20
  • 52 Week Low57.00
  • 52 Week Low Date04/15/20

Key Stats

  • Market Cap4,122.68M
  • Shares Out53.1M
  • 10 Day Average Volume341.78
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change-23.34

KEY STATS

  • Open64.54
  • Day High64.54
  • Day Low58.00
  • Prev Close58.26
  • 52 Week High115.00
  • 52 Week High Date08/06/20
  • 52 Week Low57.00
  • 52 Week Low Date04/15/20
  • Market Cap4,122.68M
  • Shares Out53.1M
  • 10 Day Average Volume341.78
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change-23.34

RATIOS/PROFITABILITY

  • EPS (TTM)4.61
  • P/E (TTM)12.64
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Profile

MORE
Emergent BioSolutions Inc. is a life sciences company. The Company focuses on protecting and enhancing life by providing specialty products for civilian and military populations that address accidental, intentional and naturally emerging public health threats. It focuses on developing, manufacturing and commercializing medical countermeasures that address public health threats (PHTs). The PHTs operates through two categories: Chemical, Biological, Radiological and Nuclear, as...
Fuad El-Hibri
Chairman
Robert Kramer Sr.
President
Richard Lindahl
Chief Financial Officer
Adam Havey
Executive Vice President
Atul Saran
Executive Vice President
Address
400 Professional Dr Ste 400
Gaithersburg, MD
20879-3457
United States